Internal Medicine, Medical Oncology · Kearney, NE
NPI
1295942530
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
7
Medicare group memberships
Hospitals
4
Hospital affiliations
909 22nd Ave
Kearney, NE, 68845
Phone (308) 296-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$329K
28,025 services
Medicare patients, 2024
283
Average age 74
Drug cost, 2024
$8.3M
2,611 prescriptions
Company payments, 2025
$497
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Swetha S Yadav was code J2916 (injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg), 1,805 times for 39 patients. In total Swetha S Yadav billed 28,025 services in 52 codes, and Medicare paid $329K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-19.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 1,805 | 39 | $1.67 | $3,019 |
| 99233 Hospital E&M - Subsequent | Facility | 635 | 127 | $94.58 | $60K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 570 | 12 | $0.24 | $134 |
| 96367 Intravenous Infusion, Hydration | Office | 381 | 53 | $21.51 | $8,197 |
| 99214 Office E&M - Established | Office | 333 | 126 | $94.54 | $31K |
| 99213 Office E&M - Established | Office | 307 | 110 | $65.25 | $20K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 280 | 52 | $0.50 | $139 |
| 96366 Intravenous Infusion, Hydration | Office | 254 | 43 | $15.77 | $4,005 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 243 | 49 | $0.62 | $151 |
| 96365 Intravenous Infusion, Hydration | Office | 227 | 43 | $48.55 | $11K |
| 96415 Chemotherapy Administration | Office | 135 | 16 | $20.95 | $2,828 |
| 99232 Hospital E&M - Subsequent | Facility | 122 | 50 | $62.87 | $7,670 |
| 96413 Chemotherapy Administration | Office | 109 | 16 | $98.35 | $11K |
| 99223 Hospital E&M - Initial | Facility | 103 | 91 | $136.75 | $14K |
| 96374 Injection Administration | Office | 61 | 14 | $28.93 | $1,765 |
By year: 2022 $201K for 19,822 services; 2023 $201K for 14,455 services; 2024 $329K for 28,025 services.
Medicare prescription drug claims, 2024
In 2024, the drug Swetha S Yadav prescribed most often to Medicare patients was Famotidine (Famotidine/Pf), with 196 prescriptions and refills. In total Swetha S Yadav wrote 2,611 Medicare prescriptions that cost $8.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Famotidine/Pf | 196 | 199 | 35 | $293 |
| Eliquis Apixaban | 178 | 214 | 55 | $123K |
| Keytruda Pembrolizumab | 166 | 166 | 19 | $2.0M |
| Granisetron Hcl Granisetron Hcl/Pf | 152 | 152 | 31 | $2,684 |
| Diphenhydramine Hcl Generic | 146 | 147 | 28 | $289 |
| Zarxio Filgrastim-Sndz | 100 | 100 | 22 | $58K |
| Dexamethasone Sodium Phosphate Generic | 89 | 91 | 19 | $248 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 82 | 82 | 26 | $1,656 |
| Opdivo Nivolumab | 72 | 72 | 11 | $986K |
| Ondansetron Hcl Generic | 71 | 71 | 30 | $7,266 |
| Granisetron Hcl Generic | 55 | 55 | 13 | $502 |
| Herceptin Trastuzumab | 45 | 45 | Under 11 | $225K |
| Carboplatin Generic | 41 | 41 | Under 11 | $1,512 |
| Prednisone Generic | 41 | 47 | 16 | $83.78 |
| Procrit Epoetin Alfa | 40 | 40 | 16 | $163K |
Brand drugs: 1,049 claims; generic drugs: 1,562 claims; opioid claims: 142.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Swetha S Yadav $497 ($497 in general payments such as food, travel and fees) from 16 companies. The largest payer was Merck Sharp & Dohme LLC with $73.09.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 3 | $73.09 |
| TerSera Therapeutics LLC | 2 | $51.76 |
| Pharmacosmos Therapeutics Inc. | 1 | $51.44 |
| Genzyme Corporation SNY | 1 | $42.87 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $38.91 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $38.32 |
| Abbvie Inc. ABBV | 1 | $31.46 |
| Caris MPI, Inc. | 1 | $25.34 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $21.22 |
| Aveo Pharmaceuticals, Inc. | 1 | $20 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.